{"id":"NCT00702845","sponsor":"Organon and Co","briefTitle":"To Investigate Efficacy and Safety of a Single Injection of Org 36286 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (Ensure)(P05690/MK-8962-001)","officialTitle":"A Phase III, Randomized, Double-blind, Active-controlled, Equivalence Clinical Trial to Investigate the Efficacy and Safety of a Single Injection of 100 µg Org 36286 (Corifollitropin Alfa) to Induce Multifollicular Development for Controlled Ovarian Stimulation (COS) Using Daily Recombinant FSH (recFSH) as a Reference","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-12-28","primaryCompletion":"2007-07-07","completion":"2007-11-15","firstPosted":"2008-06-20","resultsPosted":"2015-04-27","lastUpdate":"2024-06-18"},"enrollment":397,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Infertility"],"interventions":[{"type":"DRUG","name":"corifollitropin alfa (Org 36286)","otherNames":["Org 36286"]},{"type":"DRUG","name":"recFSH (follitropin beta)","otherNames":["recFSH (Puregon/Follistim AQ Cartridge)"]},{"type":"DRUG","name":"gonadatropin releasing hormone (GnRH) antagonist (ganirelix)","otherNames":[]},{"type":"DRUG","name":"human chorion gonadatropin (hCG)","otherNames":[]},{"type":"BIOLOGICAL","name":"progesterone","otherNames":[]},{"type":"DRUG","name":"placebo-recFSH (follitropin alfa)","otherNames":[]},{"type":"DRUG","name":"placebo-corifollitropin alfa","otherNames":[]},{"type":"BIOLOGICAL","name":"open-label recFSH","otherNames":[]}],"arms":[{"label":"corifollitropin alfa 100 µg","type":"EXPERIMENTAL"},{"label":"recFSH 150 IU","type":"ACTIVE_COMPARATOR"}],"summary":"Clinical trial objectives are to investigate the efficacy and safety of a single injection of 100 μg Org 36286 in women weighing 60 kg or less to induce multifollicular development for controlled ovarian stimulation (COS), using daily recFSH as a reference.","primaryOutcome":{"measure":"Number of Cumulus-oocyte-complexes Retrieved, Per Attempt","timeFrame":"One COS cycle with cumulus-oocyte-complex retrieval (up to a maximum total duration of 21 days)","effectByArm":[{"arm":"100 μg Corifollitropin Alfa","deltaMin":13.3,"sd":7.3},{"arm":"150 IU recFSH","deltaMin":10.6,"sd":5.9}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":21},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["20483664","26991902","26950065"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":20,"n":268},"commonTop":["Pelvic discomfort","Pelvic pain","Headache","Antepartum haemorrhage","Abortion spontaneous"]}}